AISAP Cardio vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AISAP
VS

AI Verdict

AISAP Cardio and Reveal LINQ are adjacent tools within cardiology AI, serving distinct purposes. AISAP Cardio is designed for rapid, point-of-care cardiac diagnostic assessments using ultrasound to detect structural heart disease and heart failure. In contrast, the Reveal LINQ Insertable Cardiac Monitor provides long-term, continuous ECG monitoring via an implantable device, leveraging AI to reduce false alerts and enhance the detection of arrhythmias like atrial fibrillation and syncope.

Choose AISAP Cardio if…

Choose AISAP Cardio if you need rapid, AI-powered point-of-care cardiac diagnostic assessments at the bedside. This tool is ideal for quickly identifying structural heart disease and heart failure, providing comprehensive measurements and automated reports in emergency settings or busy cardiology clinics where immediate insights are crucial.

View AISAP Cardio →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous heart monitoring for conditions like unexplained syncope or suspected atrial fibrillation. Its implantable nature and 4.5-year battery life make it superior for detecting intermittent arrhythmias that may be missed by shorter-term monitoring solutions, with AI algorithms reducing false alerts.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio Reveal LINQ Insertable Cardiac Monitor
Pricing Unknown Contact vendor
Deployment Cloud-based Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio integrates directly into existing clinical ultrasound workflows and EMR/PACS systems, streamlining the diagnostic process for clinicians at the point of care. In contrast, the Reveal LINQ ICM, while offering patient-friendly data transmission via an app, requires an invasive implantation procedure and ongoing patient engagement for data transfer.

Clinical Value

Tie

Both tools offer significant, yet distinct, clinical value. AISAP Cardio provides immediate, comprehensive diagnostic insights at the point of care for a broad range of cardiac conditions, while the Reveal LINQ ICM offers long-term, highly accurate monitoring for intermittent arrhythmias, significantly reducing false positives. Their value propositions address different stages and types of cardiac care.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, requiring direct contact with the respective vendors for quotes. Without transparent pricing or detailed cost-benefit analyses, it is impossible to objectively compare their value propositions.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Medtronic's Reveal LINQ ICM explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. As a large, established medical device company, Medtronic also offers robust infrastructure and support expected by large healthcare organizations. While AISAP Cardio is cloud-based and integrates with existing systems, explicit compliance statements were not provided in the initial facts.

Innovation

AISAP Cardio

AISAP Cardio demonstrates a high degree of innovation by bringing AI-powered, comprehensive cardiac diagnostic interpretation directly to the point-of-care ultrasound, enabling rapid and early detection of structural heart disease and heart failure. While the Reveal LINQ ICM's AI for false alert reduction is also innovative, AISAP Cardio's application of AI to democratize advanced diagnostic capabilities at the bedside represents a more transformative shift in immediate clinical assessment.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Medtronic, a global leader in medical technology, provides extensive and well-established support resources, including comprehensive documentation, patient and clinician manuals, and a dedicated support network for its devices like the Reveal LINQ ICM. Information regarding specific support and documentation for AISAP Cardio was not readily available in the provided facts or public search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio Reveal LINQ Insertable Cardiac Monitor
Product Name AISAP Cardio Reveal LINQ Insertable Cardiac Monitor
Company Aisap Medtronic
Primary Function AI-powered point-of-care ultrasound (POCUS) software for rapid cardiac diagnostic assessments and measurements. Insertable Cardiac Monitor (ICM) with AI algorithms for long-term heart monitoring, reducing false alerts.
Key AI Functionality AI-powered interpretation for early cardiac disease detection; Automated generation of analyses, interpretations, and reports; Assessment of valvular pathologies; Measurement of LVEF and ventricular dimensions. AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause); Enhanced diagnostic yield.
Specialties Cardiology, Emergency Medicine, Radiology Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform designed for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. In contrast, the Reveal LINQ Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring to reduce false alerts and enhance diagnostic yield for conditions such as atrial fibrillation and syncope.
AISAP Cardio utilizes AI for the interpretation of ultrasound images, automating the generation of analyses, interpretations, and reports for structural heart assessments, including valvular pathologies and ventricular dimensions. The Reveal LINQ ICM employs AccuRhythmu2122 AI algorithms to analyze continuous subcutaneous ECG data, specifically reducing false alerts for atrial fibrillation and pauses to improve diagnostic accuracy.
AISAP Cardio provides comprehensive cardiac measurements such as Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, IVC diameter, and assessment of valvular pathologies. The Reveal LINQ ICM delivers continuous, long-term subcutaneous ECG monitoring data, enhanced by AI to identify arrhythmias like atrial fibrillation and syncope with reduced false positives.
AISAP Cardio is a vendor-agnostic solution designed for seamless integration with existing clinical workflows, EHR/EMR, and PACS systems. The Reveal LINQ ICM transmits data to the CareLinku2122 network, allowing for remote programming capabilities and enhanced ECG experience for clinical adjudication, with reports automatically populated in the network.
AI Tool Finder
AI-powered search. Results may not be comprehensive.